Weak close for KLCI as Genting sold off


Negative news about Genting's associate TauRX Pharmaceuticals Ltd’s unsuccessful experimental results for its Alzheimer’s drug, LMTX, also weighed on the share price. Also dragging down the market was the slump in crude oil prices.

Get 20% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Business News

Budget 2027 seen offering more incentives to SMEs
MRT Corp appoints Tan Sri Wan Ahmad Dahlan Abdul Aziz as new chairman
Digital economy on track to account for 30% of GDP by 2030
Bursa Malaysia stays higher at midday
West River secures Feed-in Approval for two small hydropower projects in Perak
Malakoff sub-unit appoints contractor for SAFE-T initiative in Kemaman
AmBank posts resilient 1Q on higher net interest income
Puncak Niaga unit to dispose of Kuala Selangor land for RM237.15mil
Duopharma Biotech posts earnings jump in 1H, 1.5c div/share
US 30-year yields hit highest level since 2007 as war, oil worries fester

Others Also Read